Decheng Capital as of Dec. 31, 2023
Portfolio Holdings for Decheng Capital
Decheng Capital holds 24 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 37.7 | $135M | 7.1M | 19.06 | |
| Zentalis Pharmaceuticals (ZNTL) | 8.9 | $32M | 2.1M | 15.15 | |
| Pacific Biosciences of California (PACB) | 8.1 | $29M | 2.9M | 9.81 | |
| 10x Genomics Cl A Com (TXG) | 5.6 | $20M | 360k | 55.96 | |
| ImmunoGen | 5.5 | $20M | 660k | 29.65 | |
| Arcus Biosciences Incorporated (RCUS) | 4.6 | $17M | 870k | 19.10 | |
| Karuna Therapeutics Ord | 4.2 | $15M | 47k | 316.51 | |
| Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) | 4.0 | $14M | 1.3M | 11.23 | |
| Illumina (ILMN) | 3.1 | $11M | 81k | 139.24 | |
| Argenx SE SHS (ARGX) | 2.9 | $10M | 27k | 380.43 | |
| Acelyrin (SLRN) | 2.9 | $10M | 1.4M | 7.46 | |
| Krystal Biotech (KRYS) | 2.3 | $8.2M | 66k | 124.06 | |
| Phathom Pharmaceuticals (PHAT) | 2.2 | $7.8M | 850k | 9.13 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.6 | $5.7M | 92k | 62.00 | |
| Terns Pharmaceuticals (TERN) | 1.3 | $4.6M | 714k | 6.49 | |
| Aura Biosciences (AURA) | 1.3 | $4.6M | 516k | 8.86 | |
| BeyondSpring SHS (BYSI) | 1.2 | $4.5M | 5.0M | 0.90 | |
| Equillium (EQ) | 0.9 | $3.2M | 4.4M | 0.72 | |
| AtriCure (ATRC) | 0.5 | $1.7M | 46k | 35.69 | |
| Cue Health (HLTH) | 0.4 | $1.5M | 9.0M | 0.16 | |
| Scynexis Com New (SCYX) | 0.3 | $1.2M | 556k | 2.23 | |
| Aadi Bioscience (AADI) | 0.3 | $1.1M | 526k | 2.02 | |
| Pyxis Oncology (PYXS) | 0.2 | $588k | 327k | 1.80 | |
| GeneDx Holdings Corp. Com Cl A (WGS) | 0.1 | $285k | 104k | 2.75 |
